“…Comparatively scant research has been undertaken to discern the prevalence of cardiovascular complications associated with clonidine, especially when weighed against its beneficial effects. 12 27 A 2014 study on 40 patients undergoing cataract surgeries revealed that intravenous clonidine (4 μg/kg) administered 30 min before surgery resulted in a lower prevalence of arrhythmias and a reduced myocardial attack rate compared to the placebo group. 28 A separate investigation encompassed five hypertensive cases assessed four weeks after clonidine therapy (0.2 mg/day), revealing insignificant changes in electrocardiography or echocardiography.…”
Section: Discussionmentioning
confidence: 99%
“…8 Additionally, a study focusing on patients aged ten years without a history of heart disease displayed no alterations in electrophysiological parameters, specifically atrioventricular conduction, following intravenous administration of 150 μg clonidine at varying times postadministration. 12 In tandem with the primary emphasis of this study, the investigation also explored QTc, QT, and QRS intervals. The QRS duration remained unaltered before and after clonidine administration, indicating that the preanesthetic use of oral clonidine before general anesthesia does not extend the duration of QRS.…”
Section: Discussionmentioning
confidence: 99%
“…3 Acting selectively on α2-receptors with 200 times greater affinity than α-receptors, clonidine primarily functions as an antihypertensive agent, inhibiting norepinephrine release and consequently curbing sympathetic activity and peripheral vasodilatation. [5][6][7] Apart from its hemodynamic effects, clonidine induces negative chronotropy, hypotension, 5,[8][9][10][11][12] and exhibits sedative properties through stimulation of α2-receptors in the central nervous system. [13][14] Administered orally, clonidine boasts rapid and nearly complete absorption from the gastrointestinal tract, exhibiting 100% bioavailability.…”
Background & Objective: Clonidine, an alpha-2-agonist, plays a pivotal role in mitigating the sympathetic response during general anesthesia, thereby enhancing intraoperative hemodynamic stability. Despite its recognized benefits, reports of adverse cardiopulmonary effects have surfaced. This study investigates the impact of oral clonidine administered as premedication on patients undergoing rhinoplasty or Functional Endoscopic Sinus Surgery (FESS), with a focus on assessing alterations in the PR interval observed in postoperative electrocardiograms (ECG).
Methodology: A Randomized Clinical Trial (RCT) comprised fifty patients scheduled for rhinoplasty or FESS under general anesthesia. Each participant underwent a standard 12-lead ECG, followed by the administration of 300 µg oral clonidine 30 min prior to entering the operating room. Anesthesia induction adhered to a uniform protocol for all subjects. Comprehensive ECG monitoring throughout the surgical procedure and recovery period facilitated the recording of any observed changes. Six hours post-clonidine administration, a second standard 12-lead ECG was obtained and juxtaposed with the initial recording.
Results: Analysis revealed a lengthening of the PR interval in 23 (46%) of the cases. Within this cohort, 21 instances exhibited a prolongation falling within the normal range (0.12-0.2 sec), while the remaining two cases displayed abnormal prolongation (> 0.2 sec) (P < 0.001).
Conclusion: This investigation suggests that premedication with oral clonidine, in the patients undergoing rhinoplasty or functional endoscopic sinus surgery, has the potential to extend the PR interval.
Key words: Clonidine; PR interval; Rhinoplasty; Functional Endoscopic Sinus Surgery
Citation: Saeed R, Qazi ZUS, Shah SMA, Bukhari S, Kanwal R, Kakepotto IA. Effect of oral clonidine premedication on PR interval in patients undergoing rhinoplasty and functional endoscopic sinus surgery (FESS). Anaesth. pain intensive care 2023;27(6):731−736; DOI: 10.35975/apic.v27i6.2343
Received: August 24, 2023; Revised: November 03, 2023; Accepted: November 22, 2023
“…Comparatively scant research has been undertaken to discern the prevalence of cardiovascular complications associated with clonidine, especially when weighed against its beneficial effects. 12 27 A 2014 study on 40 patients undergoing cataract surgeries revealed that intravenous clonidine (4 μg/kg) administered 30 min before surgery resulted in a lower prevalence of arrhythmias and a reduced myocardial attack rate compared to the placebo group. 28 A separate investigation encompassed five hypertensive cases assessed four weeks after clonidine therapy (0.2 mg/day), revealing insignificant changes in electrocardiography or echocardiography.…”
Section: Discussionmentioning
confidence: 99%
“…8 Additionally, a study focusing on patients aged ten years without a history of heart disease displayed no alterations in electrophysiological parameters, specifically atrioventricular conduction, following intravenous administration of 150 μg clonidine at varying times postadministration. 12 In tandem with the primary emphasis of this study, the investigation also explored QTc, QT, and QRS intervals. The QRS duration remained unaltered before and after clonidine administration, indicating that the preanesthetic use of oral clonidine before general anesthesia does not extend the duration of QRS.…”
Section: Discussionmentioning
confidence: 99%
“…3 Acting selectively on α2-receptors with 200 times greater affinity than α-receptors, clonidine primarily functions as an antihypertensive agent, inhibiting norepinephrine release and consequently curbing sympathetic activity and peripheral vasodilatation. [5][6][7] Apart from its hemodynamic effects, clonidine induces negative chronotropy, hypotension, 5,[8][9][10][11][12] and exhibits sedative properties through stimulation of α2-receptors in the central nervous system. [13][14] Administered orally, clonidine boasts rapid and nearly complete absorption from the gastrointestinal tract, exhibiting 100% bioavailability.…”
Background & Objective: Clonidine, an alpha-2-agonist, plays a pivotal role in mitigating the sympathetic response during general anesthesia, thereby enhancing intraoperative hemodynamic stability. Despite its recognized benefits, reports of adverse cardiopulmonary effects have surfaced. This study investigates the impact of oral clonidine administered as premedication on patients undergoing rhinoplasty or Functional Endoscopic Sinus Surgery (FESS), with a focus on assessing alterations in the PR interval observed in postoperative electrocardiograms (ECG).
Methodology: A Randomized Clinical Trial (RCT) comprised fifty patients scheduled for rhinoplasty or FESS under general anesthesia. Each participant underwent a standard 12-lead ECG, followed by the administration of 300 µg oral clonidine 30 min prior to entering the operating room. Anesthesia induction adhered to a uniform protocol for all subjects. Comprehensive ECG monitoring throughout the surgical procedure and recovery period facilitated the recording of any observed changes. Six hours post-clonidine administration, a second standard 12-lead ECG was obtained and juxtaposed with the initial recording.
Results: Analysis revealed a lengthening of the PR interval in 23 (46%) of the cases. Within this cohort, 21 instances exhibited a prolongation falling within the normal range (0.12-0.2 sec), while the remaining two cases displayed abnormal prolongation (> 0.2 sec) (P < 0.001).
Conclusion: This investigation suggests that premedication with oral clonidine, in the patients undergoing rhinoplasty or functional endoscopic sinus surgery, has the potential to extend the PR interval.
Key words: Clonidine; PR interval; Rhinoplasty; Functional Endoscopic Sinus Surgery
Citation: Saeed R, Qazi ZUS, Shah SMA, Bukhari S, Kanwal R, Kakepotto IA. Effect of oral clonidine premedication on PR interval in patients undergoing rhinoplasty and functional endoscopic sinus surgery (FESS). Anaesth. pain intensive care 2023;27(6):731−736; DOI: 10.35975/apic.v27i6.2343
Received: August 24, 2023; Revised: November 03, 2023; Accepted: November 22, 2023
“…Existem controvérsias em relação ao efeito da clonidina na fisiologia cardíaca. Alguns autores relatam que a clonidina não altera o ritmo cardíaco (TOUSSAINT et al, 1984), enquanto outros sugerem que esse fármaco reduz a velocidade de condução do estímulo elétrico cardíaco (CLEMENTY et al, 1986). Dessa forma, a clonidina deve ser evitada em animais portadores de cardiopatias, pois, em pacientes predispostos, esse fármaco pode desencadear arritmias (EISENACH et al, 1989).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.